Diagnostic value of gadolinium contrast administration for spinal cord magnetic resonance imaging in multiple sclerosis patients and correlative markers of lesion enhancement.

Kianush Karimian-JaziUlf NeubergerKatharina SchregelGianluca BrugnaraMartin BendszusMichael O BreckwoldtDaniel SchwarzLaura Bettina JägerWolfgang Wick

Published in: Multiple sclerosis journal - experimental, translational and clinical (2021)

Gadolinium contrast administration is dispensable in follow-up spine magnetic resonance imaging if no new T2 lesions are present. Probability of enhancement correlates with the T2 signal ratio.

Keyphrases

contrast enhanced
magnetic resonance imaging
multiple sclerosis
spinal cord
end stage renal disease
magnetic resonance
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
computed tomography
spinal cord injury
prognostic factors
neuropathic pain
patient reported outcomes